Results 311 to 320 of about 15,797,569 (411)

April 26, 2002 [PDF]

, 2002
Lumpkin College of Business and Applied Sciences
core   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

Molecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez, Pablo Juanes‐Velasco, Marina L. García‐Vaquero, Conrad Droste, Alicia Landeira‐Viñuela, Miguel Alcoceba, Helena Fidalgo‐Gómez, Sara Misiego‐Herrero, Almudena Navarro‐Bailón, Mónica Baile, José M. Bastida, Jose Manuel Sanchez‐Santos, Rafael Góngora, Julia Almeida, Marcos Gonzalez‐Diaz, Alberto Orfao, Javier De Las Rivas, Manuel Fuentes   +17 more
wiley   +1 more source

Legacy DDT and its metabolites in Brook Trout from lakes within forested watersheds treated with aerial applications of insecticides. [PDF]

PLoS One
Kurek J, Fraser MP, Nakamoto BJ, Kidd KA, Edge CB.   +4 more
europepmc   +1 more source

March 25, 2004 [PDF]

, 2004
Lumpkin College of Business and Applied Sciences
core   +1 more source

Ubiquitination of transcription factors in cancer: unveiling therapeutic potential

Molecular Oncology, EarlyView.
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley   +1 more source

Correction: Shewanella oneidensis and Methanosarcina barkerii augmentation and conductive material effects on long‑term anaerobic digestion performance. [PDF]

Biotechnol Biofuels Bioprod
Perego C, König R, Cuomo M, Pianta E, Maye S, Di Maggio L, Moser M, Fischer F, Principi P.   +8 more
europepmc   +1 more source

February 2, 1993 [PDF]

, 1992
Lumpkin College of Business and Applied Sciences
core   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

Exploring views and experiences of childbirth-related perineal trauma: a qualitative study protocol for developing a wound management tool and care pathway. [PDF]

BMJ Open
Jones L, Delicate A, Waigwa S, Hodgetts Morton V, Morris RK, Whitehurst J, Hillman S, Chapter Collaborative Group.   +7 more
europepmc   +1 more source

Applied nuclear science research and development progress report, June 1, 1985-November 30, 1985

, 1986
E.D. Arthur, A.D. Mutschlecner
openalex   +2 more sources